AstraZeneca’s rare disease arm in $1 billion deal for Pfizer gene therapies
By Yadarisa Shabong (Reuters) -AstraZeneca said on Friday its Alexion unit had agreed to buy U.S. drugmaker Pfizer’s early-stage rare…
Centene aims to enroll back some lost Medicaid members
By Mariam Sunny and Leroy Leo (Reuters) -Centene Corp said on Friday it was working to enroll people back into…
Drugmakers go under the skin, skirting early US Medicare price negotiations
By Michael Erman NEW YORK (Reuters) – Injectable versions of some widely-used cancer drugs including Johnson & Johnson’s blockbuster multiple…
Softening inflation props up U.S. consumer sentiment
By Safiyah Riddle (Reuters) – Diminishing inflation pushed consumer sentiment to the highest in nearly two years, a closely watched…
Brazil set to kick off monetary easing with small rate cut on Aug 2: Reuters poll
By Luana Maria Benedito and Marcela Ayres SAO PAULO (Reuters) – Brazil’s central bank is poised for its first interest…
Vietnam EV maker VinFast to list in the U.S. in August after regulator nod
HANOI (Reuters) -Vietnamese electric vehicle maker VinFast said on Friday it is planning to list in the United States next…
France and Spain give euro zone economy a boost before outlook darkens
(Corrects first paragraph to show Spanish resilience, not German) PARIS/MADRID (Reuters) – The French and Spanish economies displayed unexpected resilience…
P&G tops estimates on higher prices but signals slowing China demand
By Ananya Mariam Rajesh and Kailyn Rhone (Reuters) -Procter & Gamble on Friday beat analysts’ estimates for quarterly sales and…
Japan set for largest ever minimum wage hike after panel proposal
TOKYO (Reuters) – A Japanese government panel recommended on Friday that the national average minimum wage be raised by 41…
Enphase Energy slumps as lukewarm US demand weighs on revenue forecast
(Reuters) -Shares of Enphase Energy slumped nearly 11% on Friday, after the solar inverter maker’s third-quarter revenue target fell well…